Aston Clinton Scientific was founded in1982, incorporated into a limited company in 1997 and in 2000 entered into a business partnership with Otto Schill GmbH in Germany to promote Schill Multisonic Nebulisers under the trade name Schill Medical. This partnership has launched the Schill range of Multisonic nebulisers onto the UK market.

Schill Nebulisers offer silent drug delivery for the treatment of asthma, chronically obstructive pulmonary disease (COPD), cystic fibrosis, pulmonary hypertension, pulmonary emphysema and other respiratory disorders and enable the patient to receive treatment in hospital, in a clinic, at home, in a car and when traveling.

This technology offers many chronically ill patients the opportunity to have a reasonable life style subject to compliance, and enjoy freedom not previously possible. Patients suffering from pulmonary hypertension treated at Papworth Hospital, Cambridge; Freeman Hospital, Newcastle-Upon-Tyne; Royal Hallamshire Hospital, Sheffield; Great Ormond Street Hospital for Sick Children London; Royal Free Hospital, London; Glasgow Western Infirmary; Royal Victoria Hospital, Belfast; Mater Hospital, Dublin; University Hospital of Giessen in Germany, and other European centre's, have benefited from the treatment by nebulised drug therapy delivered by Schill nebulisers in the last few years. Patients have tolerated nebulised treatment well with no significant side effects. The new Infracontrol, profi and top nebulisers offer travel versatility and operate by rechargeable battery, mains or car cigar lighter power sources.